Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
The company is engaged in manufacturing of medicines. It provides cardivasculars and endocrine, urinary and skeletal system.
Medibios Laboratories Limited, was an unlisted public company incorporated on 08 March, 1995. It is classified as a public limited company and is located in , Maharashtra. It's authorized share capital was INR 10.00 cr and the total paid-up capital was INR 7.10 cr.
Read more
** All rupee values in INR crores. Based on March 2021 numbers.
Tofler currently has no financial reports
for this company due to a lack of available
information. This may be because the company
is dormant or closed (see company status)
or because it was formed only recently
(check the incorporation date) and financial data
is not yet available.
You can view basic information by scrolling through the page.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Managing Director | Tushar Anil Korday
Shareholder
|
00738316 | 15 years |
Whole-time Director | Rajendra Fattesinh Gole
Shareholder
|
00738346 | 7 years |
Director | Yogesh Rajendra Gole
Shareholder
|
03443157 | 14 years |
Director | Meena Sanjiv Kapadi | 08074814 | 7 years |
Director | Sharad Kantilal Sheth | 08090542 | 7 years |
CS | Sangeeta Amitkumar Dhanuka | <HIDDEN> | 7 years |
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
As per information available, the company has no registered charges.
Name | Status | Paid up Capital | Common Directors | Address |
---|---|---|---|---|
BIOVY HEALTHCARE PRIVATE LIMITED |
Strike Off
|
1.0 L | 2 | Maharashtra |
EMIL PHARMACEUTICAL INDUSTRIES PRIVATE LIMITED |
Active
|
21.3 Cr | 2 | Maharashtra |
EMIL HOLDINGS PRIVATE LIMITED |
Active
|
1.6 L | 2 | Maharashtra |
EMIL HEALTHCARE PRIVATE LIMITED |
Active
|
2.7 L | 2 | Maharashtra |
FLAMINGO PHARMACEUTICALS LIMITED |
Active
|
6.8 Cr | 1 | Maharashtra |
PRIME PROPERTY DEVELOPMENT CORPORATION LIMITED |
Active
|
8.5 Cr | 1 | Maharashtra |
B4U TELEVISION NETWORK INDIA LIMITED |
Active
|
30.3 Cr | 1 | Maharashtra |
B4U BROADBAND (INDIA) PRIVATE LIMITED |
Active
|
117.3 Cr | 1 | Maharashtra |
Read more
The incorporation date of MEDIBIOS LABORATORIES LIMITED is 08 March, 1995
The authorized share capital of MEDIBIOS LABORATORIES LIMITED is INR ₹ 10.0 Cr.
The paid-up capital of MEDIBIOS LABORATORIES LIMITED is INR ₹ 7.1 Cr.
The registered address of MEDIBIOS LABORATORIES LIMITED is 102,SHREE MANGALAM,1ST FLOOR,KULUPWADI,BORIVALI(E) NA MUMBAI Maharashtra - 000000
The CIN number of MEDIBIOS LABORATORIES LIMITED is U24230MH1995PLC086180.